Jim Cramer's Mad Money Review

This site is dedicated towards tracking Jim Cramer's stock picks on his TV show Mad Money. Read about and discuss Jim Cramer's ability to move markets. Be ahead of the stock market. Get the news before its news.

Thursday, January 18, 2007

Jim Cramer's Mad Money Lightning Round Jan. 17

Bullish calls:
NYSE Group (NYSE: NYX - News): 'NYX is still my growth stock of the year.'Altria (NYSE: MO - News): ' ... that's my number 1 value stock of the year, and we've been making money in that name. 'Public Storage (NYSE: PSA - News): 'PSA is one of those incredible situations where I believe... this group's in bull market mode, and it is not about to stop, and I think PSA is two thumbs up, way up!'Tower Group (NASDAQ: TWGP - News): ' I like the insurance business. Obviously, a little expensive versus price to book, because it sells at like 4x book. But it's growth rate is equal to its P/E multiple.'Transocean (NYSE: RIG - News)GlobalSantaFe (NYSE: GSF - News)Wells Fargo (NYSE: WFC - News): 'WFC - best in show quarter.'JPMorgan (NYSE: JPM - News): 'I suggest you swap into JPM.' WFC - best in show quarterJ.C. Penney (NYSE: JCP - News): 'Let me just tell you to be in some JCP.'
Bearish calls:
General Motors (NYSE: GM - News): 'GM is in a holding pattern. It can't do anything until the numbers start getting better. Had they not lost Jerry York ... the stock would have gone to $40. Right now, it is strictly 'don't buy, don't buy...'Hertz Global (NYSE: HTZ - News): ' Take the money and run! I don't want to be there.'Intercontinental Exchange (NYSE: ICE - News): 'The ICE still does not melt... I do not understand why this stock is so strong, other than it trades oil... I still like NYX more. Don't buy, don't buy.'LoJack (NASDAQ: LOJN - News): 'They missed the quarter.'Del Monte Foods (NYSE: DLM - News): ' ... it has been historically a bad investment, and it's not going to change. That company is poorly run!'ON Semiconductor (NASDAQ: ONNN - News): 'No, no, no. Time to ring the register. That particular part of the tech bull market is on hold until August.'DivX (NASDAQ: DIVX - News): 'We recommended it at $18. It was a fabulous call. We pulled the trigger. When it got to $28, we said enough is enough. It's back to $21. I'm not going away from that.'King Pharmaceuticals (NYSE: KG - News): ' ... I have disliked KG for as long as this stock has been going down. I don't like the generics. I reiterate my sell on KG. 'Tata Motors (NYSE: TTM - News): 'I cannot in good conscience say that I am going to recommend that you buy it, but I am certainly, certainly going to tell you - if you own TTM - you can hold it, but you better do a little schnitzelling...'Hercules Offshore (NASDAQ: HERO - News): 'This is an example of the need to be selective. I want you to sell HERO. I don't like the U.S. offshore market.'The Bank of New York (NYSE: BK - News): ' I'm not a big fan of stocks that have already announced big deals.'Aeropostale (NYSE: ARO - News): 'No. I don't need that teen ghetto - it's too hard for me.'
Published by SeekingAlpha

Labels: , , , , , , , , , , , , , , , , , , ,

Monday, January 08, 2007

Moday's Biggest Gainers and Losers

AdvancersAffymetrix (NASDAQ:AFFX - News) shares rose 14% Monday after the company forecast revenue of about $100 million for the fourth quarter. The current average estimate of analysts polled by Thomson First Call is for revenue of $99.5 million in the December period. The Santa Clara, Calif., biotechnology company plans to release its results for the fourth quarter and full year after the closing bell on Feb. 7.
Hauppage Digital (NASDAQ:HAUP - News) shares gained 6.3% after the company unveiled a line of four TV tuner products designed to support Microsoft's Vista Media Center.
Houston Exploration (NYSE:THX - News) shares added 4.1% after the company agreed to be acquired by Forest Oil (NYSE:FST - News) for $52.47 a share. That's 8% above Friday's closing price but below the $62 a share that a hedge fund offered Houston Exploration last summer.
Incyte Pharmaceuticals (NASDAQ:INCY - News) shares rose 5.3% after the company was upgraded to outperform from market perform at Piper Jaffray. The firm also lifted its price target on the stock to $8 from $4.
IntraLase Corp. (NASDAQ:ILSE - News) shares added 10% after the company agreed to be acquired for $25 a share, or $808 million, by Advanced Medical Optics Inc. (NYSE:EYE - News) That's 12.5% over IntraLase's closing price on Friday.
Nautilus Inc. (NYSE:NLS - News) shares rose 13% after the company formed a partnership with the National Academy of Sports Medicine. The deal calls for Nautilus to provide research and training support for new fitness products. Financial terms weren't disclosed. In addition, the company was upgraded to neutral from sell at Merriman Curhan Ford & Co.
ON Semiconductor (NASDAQ:ONNN - News) shares rose 7.2% after the company was upgraded to overweight from equal weight at Lehman Bros. on valuation.
Quebecor World Inc. (NYSE:IQW - News) plans to close its L'Eclaireur facility in Beauceville, Quebec, impacting about 155 employee positions. The closure is part of the company's plan to consolidate its Quebec-based magazine and catalog printing operations. Quebecor World said it continues to employ about 2,000 employees at seven facilities in Quebec
Quigley Corp. (NASDAQ:QGLY - News) shares advanced 11% after its Quigley Pharma subsidiary said a preliminary study has demonstrated its QR-441(a) compound to be a potential antiviral agent in reducing infectious bronchitis and New Castle disease, two viral poultry diseases. The Doylestown, Pa.-based company said QR-441(a) showed positive results in a study evaluating the compound in embryonating egg and VERO E6 cell test models.
RadioShack Corp. (NYSE:RSH - News) shares rose 12% after the company said fourth-quarter net income will rise from the $51 million the consumer electronics retailer earned in the year-ago quarter, but same-store sales will drop.
Savient Pharmaceuticals' (NASDAQ:SVNT - News) shares added 9.3% after the East Brunswick, N.J.-based company announced late Friday that, as part of its restructuring of its commercial operations, it will discontinue its 19-person Oxandrin field sales force. The move follows the company's launch of oxandrolone, the generic version of Oxandrin.
Scopus Video Networks Ltd. (NASDAQ:SCOP - News) shares rose 7.5% after the Israel-based provider of digital video networking products said a large cable multi-service operator in India has selected Scopus' broadcast platforms for several projects in connection with a direct-to-home digital cable service deployment. The projects have a value of over $3 million, Scopus said.
Seattle Genetics (NASDAQ:SGEN - News)shares jumped 24% after the company said it entered a license agreement with Genentech (NYSE:DNA - News) to develop cancer treatment SGN-40, which is currently undergoing Phase I and Phase II clinical trials. As part of the agreement, Seattle Genetics will receive an up-front payment of $60 million and could receive milestone payments of as much as $800 million, as well as potential royalties on sales.
Skechers USA (NYSE:SKX - News) shares climbed 6.2% after the company lifted its outlook for the fourth quarter to earnings of 28 to 31 cents a share on revenue of between $295 million and $300 million. The Manhattan Beach, Calif., footwear provider previously forecast a profit of 22 to 27 cents a share for the period on revenue of $255 million and $265 million. For the full year, the company now sees earnings of $1.55 to $1.58 a share on revenue of between $1.196 billion and $1.201 billion. Skechers' prior projection for fiscal 2006 was for a profit ranging from $1.49 to $1.54 a share on revenue of $1.156 billion to $1.666 billion.
St. Jude Medical (NYSE:STJ - News) shares gained 5.6% after the company said it expects fourth-quarter earnings of 42 cents a share. Analysts surveyed by Thomson First Call forecast earnings of 39 cents a share, on average. The St. Paul, Minn. medical device company will report net sales of approximately $864 million for the fourth quarter, an increase of more than 9% compared to the year-ago period and approximately $20 million above current analysts' consensus revenue estimates, the company said.
Telestone Technologies Corp. (NASDAQ:TSTC - News) shares rose 12% after the Beijing-based provider of wireless services said it has been awarded bids from four regional telecom operators. The company said it was awarded indoor coverage system equipment contracts from the Sichuan Telecom subsidiary of China Telecom; the Guizhou Unicom subsidiary of China Unicom; the Heibei Netcom subsidiary of China Netcom; and the Jiangxi Telecom subsidiary of China Telecom. Financial terms of the contracts were not disclosed.
Therma-Wave Inc. (NASDAQ:TWAV - News) shares surged 29% after the company agreed to be acquired for $1.65 a share, or $75 million, by KLA-Tencor. (NASDAQ:KLAC - News) The offer represents a 25% premium to Therma-Wave's closing price on Friday. KLA-Tencor, which provides semiconductor manufacturing systems, said the deal will strengthen its customers' access to Therma-Wave's advanced measurement capabilities.
United Surgical Partners (NASDAQ:USPI - News) shares rose 12% after the company said it was being acquired by an affiliate of Welsh, Carson, Anderson & Stowe affiliate for $1.8 billion in cash and debt. UNCN will pay $31.05 for each United Surgical share, a 13% premium to Friday's closing price of $27.39.
Decliners
BioCryst Pharmaceuticals (NASDAQ:BCRX - News) shares lost 10% Monday after the company named Jon Stonehouse its chief executive. BioCryst, a Birmingham, Ala., drug development company, said Stonehouse succeeds Charles Bugg, the company's founder and CEO. Bugg will become nonexecutive chairman. Stonehouse had been senior vice president of corporate development at Merck KGaA.
Compucredit Corp. (NASDAQ:CCRT - News) shares fell 5.8% after the company said in a filing with the Securities and Exchange Commission that it now expects earnings for the fourth quarter to come about 20% below its previous projections.
Delta Apparel Inc. (AMEX:DLA - News) shares dropped 8% after the company said it expects second-quarter sales of $72 million to $73 million, down from a previous estimate of $74 million to $78 million, and earnings of 5 cents to 7 cents a share, down from a prior projection of 14 cents to 18 cents a share. Delta Apparel also cut its forecast for the year's sales and earnings.
Dynavax Technologies Corp. (NASDAQ:DVAX - News) shares plunged 30% after the Berkeley, Calif.-based biotech company said interim one-year data from its two-year ragweed allergy trial indicated that "no meaningful ragweed-specific allergic disease was observed in the study population," making it impossible for the company to measure the impact of its Tolamba treatment. "This result was unexpected, though these challenges are well known to occur in allergy drug development," said Dino Dina, president and chief executive, in a statement. "Due to the fact that no clinically significant disease was seen in the study population, it was impossible to measure the effect of our intervention."
MarineMax Inc. (NYSE:HZO - News) shares fell 11% after the company said it sees a first-quarter loss of 20 cents to 25 cents a share; the First Call-derived average forecast stands at a loss of 6 cents. The company also lowered its profit outlook for fiscal 2007.
Medecision (NASDAQ:MEDE - News) shares plummeted 41% after the Wayne, Pa.-based a provider of software and services to healthcare payers said late Friday it expects fourth-quarter revenue of $10.3 million to $10.6 million. MEDecision said it signed five contracts during the quarter, resulting in lower-than expected term license revenue of between $1.1 million and $1.3 million.
Molex Inc. (NASDAQ:MOLX - News) shares sank 4.9% after the company lowered its second-quarter earnings and sales outlook citing lower-than-anticipated gross margins, which is due primarily to lower sales and higher price erosion in its mobile phone business. The Lisle, Ill. electronics components maker now expects to earnings of 34 to 37 cents a share vs. its previous forecast of 39 to 43 cents a share. Revenue is expected to be $830 million to $840 million, revised from a previous projection of $830 million to $850 million. The company also sees new orders slowing to $770 million to $780 million.
Novastar Financial (NYSE:NFI - News) shares lost 5.1% after the company was downgraded to market perform from market outperform at JMP Securities.
Nu Horizons Electronics (NASDAQ:NUHC - News) shares sank 7.2% after the company said net income rose 59% to $2.4 million, or 13 cents a share, for its fiscal third quarter ended Nov. 30 with sales up 26% to $186 million. From the last quarter, however, sales fell at the electronic components distributor, due to a decline in the company's systems business related to a substantial customer-specific decrease, as well as to market weakness related to some end customer and manufacturing channel inventory builds.
Schnitzer Steel Industries (NASDAQ:SCHN - News) shares dropped 7.4% after the company reported first-quarter earnings of $21 million, or 69 cents a share, down from a year-ago profit of $42 million, or $1.34 a share. The year-ago results included a gain of $34 million related to an asset disposition as well as a charge of $11 million from an investigation reserve. Excluding items, Portland, Ore.-based Schnitzer earned $19 million, or 61 cents a share, in the year-ago period. Revenue rose in the latest three months to $510 million from $341 million in the same period a year earlier. The average estimate of analysts polled by Thomson First Call was for a profit of 99 cents a share in the November period on revenue of $511.9 million. The company said it saw lower volumes and higher costs per ton in the latest quarter due to the installation of mega-shredders at its metals recycling facilities in the Oakland and Boston areas. In addition, margins were hurt by higher raw material costs in the quarter, and its auto parts business saw lower vehicle purchases due to higher prices.
Targeted Genetics Corp. (NASDAQ:TGEN - News) shares lost 20% after the company agreed to sell 2.18 million shares to institutional investors at a price of $4 each. The transaction includes warrants to purchase up to 763,000 shares, exercisable at price of $5.41 per share. The Seattle-based biotechnology company expects net proceeds of $8.1 million from the transaction, which is expected to close Jan. 11. Targeted Genetics plans to use the funds for working capital and general corporate purposes.
Published by MarketWatch

Labels: , , , , , , , , , , , , ,

Thursday, December 28, 2006

The 2006 Noisey Awards - Part 1

Best CEO Ouster Award: North America's largest sweater maker, Hampshire Group Ltd. (Nasdaq: HAMP - News), canned CEO Ludwig Kuttner in September for submitting $1.45 million in questionable expense reports over a ten-year period. Kuttner also happens to be Hampshire Group's largest shareholder, owning a more than 33% stake. No word on whether the security guards were wearing cardigans when Kuttner was escorted from the building.
Favorite New Institutional Investor: Former major league baseball player Lenny Dykstra, who disclosed a 7% stake in Lipid Sciences, Inc. (Nasdaq: LIPD - News) in November. Fortune recently profiled Dykstra, who claims to be worth $50 million now. His investment in Lipid has proved limp thus far, but Dykstra's nickname as a player was "nails" (as in, "tough as nails").
Patrick Byrne Worst CEO of the Year Award: For the second-consecutive year, Patrick Byrne of Overstock.com Inc. (Nasdaq: OSTK - News) took home the award named after himself. Byrne's list of "achievements" was long in 2006, but it was his raising of cash twice via private placements - after telling shareholders numerous times that the company's liquidity was fine - that clinched the deal. With his paranoid delusions and obvious ignorance of the day-to-day operations of his company (listen to Overstock's third-quarter conference call), Byrne also takes home the Richard Nixon Final Days Award.
The Batman Award: He's not Bruce Wayne, but Matthew Feshbach is as close as we're going to come to Batman in real life. Back in May, the chairman of dELiA*s, Inc. (Nasdaq: DLIA - News) told The St. Petersburg Times that he was the first person "to take a highly classified Scientology program called Super Power." Feshbach, a noted short seller turned value investor, told journalist Robert Farley, "I'm not dependent on my physical body to perceive things." According to Feshbach, Super Power has allowed him to outperform his peers in the money management business. It also gives him a leg up on fellow Scientologist Tom Cruise, who has to settle for sleeping next to Katie Holmes every night.
Walt Disney Award: Future Electronics, a Canadian electrical component distributor, recently took a 6.2% stake in ON Semiconductor Corp. (Nasdaq: ONNN - News). Future is headed by Robert Miller, a reclusive billionaire who has never been photographed and who is leaving some of his fortune to ensure that he is cryogenically frozen. Miller also reportedly flew in two former NHL players at the last minute during an amateur hockey tournament last year. His team, not surprisingly, won.
Unwired Award: Gunmaker Sturm, Ruger & Co. Inc. (NYSE: RGR - News) saw its stock blast off in early November after the company posted solid third-quarter results and two insiders at the company bought stock. Sturm, Ruger reported those Q3 results on October 23rd, filing a Form 8-K with the Securities and Exchange Commission two days later disclosing its earnings. The company, however, never issued a press release publicly (though it was available on Bloomberg terminals and via Dow Jones Newswires). Even now, Sturm, Ruger still has not posted its Q3 earnings release on its website.
Favorite Insider of the Year: Josiah T. Austin, who with a name like that can only be a cattle rancher. Austin is also a director at Goodrich Petroleum Corp. (NYSE: GDP - News), where from May 2005 to October 2006 he plowed $14.8 million into the stock at an average price of just $21.21 per share. Austin also sat on the board of North Fork Bancorp., Inc., which was recently acquired by Capital One Financial Corp. (NYSE: COF - News). Austin's holdings in North Fork were valued at over $100 million ahead of the deal, and the total value of his public holdings is more than $350 million. Not bad for someone most people have never heard of.
Published by Ben Silverman, FindProfit.com

Labels: , , , , , , ,

Stock Watch List for Thursday

Alcoa Inc. (AA : News , chart, profile, more, Last: 30.02+0.65+2.21%) said UAW Local 1050 has ratified a new 4-year labor agreement that covers about 830 employees at the company's Cleveland Works facility. The aluminum company said the UAW represented employees will return to work Jan. 2 after an 8-week strike.
BioForm Medical Inc. said the Food and Drug Administration has approved Radiesse, a cosmetic dermal filler for the long-lasting correction of moderate to severe facial wrinkles and folds. Shares of BioForm's competitor, Medicis Pharmaceutical Corp. (MRX : News , chart, profile, more, Last: 35.53-0.24-0.67%), which makes wrinkle-treatment Restylane, closed down 0.67%.
Champion Industries Inc. (CHMP : News , chart, profile, more, Last: 6.75-0.07-1.02%) reported fiscal fourth-quarter net earnings of $1.97 million, or 20 cents a share, up from $569,000, or 6 cents a share, in the year-ago period. Revenue in the three months ended Oct. 31 rose 6.6% to $37 million from $34.7 million.
Directed Electronics Inc. (DEIX : News , chart, profile, more, Last: 11.53+0.28+2.49%) said Ronald Dutt, executive vice president for finance, operations and legal, will be appointed chief financial officer and treasurer, effective Jan. 2. The Vista, Calif.-based designer and marketer of home theater loudspeakers, said Dutt will succeed John Morberg, who is leaving the company.
ON Semiconductor Corp. (ONNN : News , chart, profile, more, Last: 7.51+0.11+1.49%) said it has agreed to repurchase $70 million of its shares from TPG Semiconductor Holdings LLC and TPG ON Holdings LLC, which together are the company's largest stockholder.
Sento (SNTO : News , chart, profile, more, Last: 3.24+1.32+68.75%) said it swung to a second-quarter net loss attributable to stockholders of $2.58 million, or 65 cents, due to higher costs of sales after the termination of a client program. In the same period last year, the Salt Lake City-based provider of call center services posted net earnings of $310,000, or 8 cents a share.
Standard & Poor's said First Cash Financial Services Inc. (FCFS : News , chart, profile, more,
Last: 23.53+0.37+1.60%) will replace Republic Bancorp Inc. (RBNC : News , chart, profile, more, Last: 14.48+0.36+2.55%) in the SmallCap 600 index after the close of trading on Friday. Citizens Banking Corp. (CBCF : News , chart, profile, more, Last: 28.06+0.56+2.04%) is acquiring Republic in a deal expected to close on or about that date.
Tapestry Pharmaceuticals Inc. (TPPH : News , chart, profile, more, Last: 1.82-0.02-1.09%) named Donald Picker as president, effective Jan. 2. Picker was most recently executive vice president of research and development at Callisto Pharmaceuticals.
Threshold (THLD : News , chart, profile, more, Last: 3.20+0.10+3.23%) said it is pleased with the results from the Phase 2 clinical trial of glufosfamide in combination with gemcitabine for the treatment of advanced pancreatic cancer. The cancer treatments developer said 21% of patients in the clinical trial had a partial response.
VCA Antech (WOOF : News , chart, profile, more, Last: 32.29-0.03-0.09%) said it sees 2007 revenue of $1.05 billion to $1.08 billion. The operator of veterinary hospitals said it sees annual income of $109 million to $113 million, and per-share income of $1.27 to $1.31.
Published by MarketWatch

Labels: , , , , , , , , , , ,